Skip to Content
MilliporeSigma
  • Prevalence and Susceptibility Pattern of Multi Drug Resistant Clinical Isolates of Pseudomonas aeruginosa in Karachi.

Prevalence and Susceptibility Pattern of Multi Drug Resistant Clinical Isolates of Pseudomonas aeruginosa in Karachi.

Pakistan journal of medical sciences (2014-09-17)
Fouzia Khan, Adnan Khan, Shahana Urooj Kazmi
ABSTRACT

To determine the frequency and susceptibility pattern of multi-drug resistant (MDR) Pseudomonas aeruginosa isolated from clinical specimens in Karachi. This cross sectional study was conducted in Microbiology Department, University of Karachi, from January 2012 to January 2013. Clinical specimens were collected from different hospitals of Karachi. Clinical isolates were identified by standard and specific microbiological methods. The antibiotic susceptibility pattern was determined by Kirby Bauer Disc diffusion method. Clinical and Laboratory Standards Institute (CLSI) guidelines were used to determine the results. The frequency of MDR P. aeruginosa isolated from different clinical specimens was found to be 30%. Amikacin was found to be the most effective antibiotic, followed by Co-trimaxazole and Quinolones. Antibiotic resistant P. aeruginosa are emerging as a critical human health issue. There is an urgent need to resolve the issue by taking some preventive measures. Combined efforts of health care professionals and researchers are required to educate people about the proper use of antibiotics and other infection control measures.

MATERIALS
Product Number
Brand
Product Description

USP
Cystine, United States Pharmacopeia (USP) Reference Standard
Cystine, European Pharmacopoeia (EP) Reference Standard
USP
Meropenem, United States Pharmacopeia (USP) Reference Standard
USP
Amikacin, United States Pharmacopeia (USP) Reference Standard
USP
Piperacillin, United States Pharmacopeia (USP) Reference Standard
Amikacin, European Pharmacopoeia (EP) Reference Standard
Ciprofloxacin, European Pharmacopoeia (EP) Reference Standard
Piperacillin, European Pharmacopoeia (EP) Reference Standard
Supelco
Cefuroxime, VETRANAL®, analytical standard
Supelco
Ciprofloxacin, VETRANAL®, analytical standard
Sigma-Aldrich
Nalidixic acid, ≥98%
Sigma-Aldrich
Ciprofloxacin, ≥98% (HPLC)
Supelco
Ciprofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material